GRANDVILLE, Mich., Aug. 26, 2014 /PRNewswire/ -- Alternaturals, Inc., Symbol (OTCPink:ANAS) today announced that it has recruited Mark Figula (dba Mark Tiarra) as it's new Chief Technology Officer to lead an aggressive online advertising sales campaigns.

"To say that Mr. Tiarra has proven his expertise would be the understatement of the century, for eighteen years he's honed his skills and is known for generating astronomical results. His expertise and industry connections are just what we need to generate meaningful revenue streams that last. I couldn't be more excited for the upcoming months," said CEO, Matthew Briggs.

Mr. Tiarra has been building successful online ventures since 1996 and has proven time and time again to have a complete understanding of what it takes to build Internet based revenue streams for any number of products.  He has been featured in numerous major publications from The New York Times, Forbes, to Wired.  He has been a highly sought after consultant for the better part of two decades.  It is a major coup to have Mr. Tiarra on board on a full time basis.

"I am very excited to be here at a time when this company is poised to leap forward into new directions and bring to bear so much untapped potential.  I have already seen tremendous results, working with Internet marketers on these types of products.  The ability to be involved on a level more significant than a consulting arrangement was too appealing to pass up.  I've also seen the kind of energy and flow of ideas that the CEO brings to the table and recognize the 'symptoms of success' in his approach.  I look forward to building out the Alternaturals Internet affiliate program and with it, bringing the kinds of results that I have been accustomed to with my consulting clientele."

For more information, contact Investor Relations at : 1-616-244-8500 or IR@alternaturals.com

About Alternaturals, Inc.
Alternaturals, Inc. is a manufacturer and distributor of supplements and all-natural remedies that are alternatives to prescription drugs. The company has two popular products, Focamine© and Sombium© and has many proprietary formulas in several natural-remedy related industries that are scheduled for release during the next twelve months. For more go to www.alternaturals.com, or @alternaturals on twitter.

DISCLAIMER
This Press Release may contain certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The Company has tried, whenever possible, to identify these forward-looking statements using words such as "anticipates," "believes," "estimates," "expects," "plans," "intends," "potential" and similar expressions. These statements reflect the Company's current beliefs and are based upon information currently available to it. Accordingly, such forward-looking statements involve known and unknown risks, uncertainties and other factors which could cause the Company's actual results, performance or achievements to differ materially from those expressed in or implied by such statements. The Company undertakes no obligation to update or advise in the event of any change, addition or alteration to the information catered in this Press Release including such forward-looking statements.

SOURCE Alternaturals, Inc.

Copyright 2014 PR Newswire

Alternaturals (PK) (USOTC:ANAS)
Gráfica de Acción Histórica
De Nov 2024 a Dic 2024 Haga Click aquí para más Gráficas Alternaturals (PK).
Alternaturals (PK) (USOTC:ANAS)
Gráfica de Acción Histórica
De Dic 2023 a Dic 2024 Haga Click aquí para más Gráficas Alternaturals (PK).